Endoscopy 2025; 57(08): 839-848
DOI: 10.1055/a-2541-2312
Original article

In-hospital mortality in patients with lower gastrointestinal bleeding: development and validation of a prediction score

Authors

  • Elton Dajti

    1   Gastroenterology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
    2   Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy
  • Leonardo Frazzoni

    3   Gastroenterology and Digestive Endoscopy Unit, Forlì-Cesena Hospitals, AUSL Romagna, Forlì, Italy
  • Sílvia Castellet-Farrús

    4   Department of Gastroenterology, Hospital Bellvitge, L’Hospitalet, Barcelona, Spain
  • Jordi Guardiola

    4   Department of Gastroenterology, Hospital Bellvitge, L’Hospitalet, Barcelona, Spain
  • Emanuele Sinagra

    5   Gastroenterology and Endoscopy Unit, Fondazione Istituto S. Raffaele-G. Giglio, Cefalù, Italy
  • Andrea Anderloni

    6   Gastroenterology and Digestive Endoscopy Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
  • Francesco Ferrara

    7   Gastroenterology Unit, University Hospital of Padova, Padova, Italy
  • Paraskevas Gkolfakis

     8   Department of Gastroenterology, "Konstantopoulio-Patision" General Hospital of Nea Ionia, Athens, Greece
  • Marine Camus Duboc

     9   Centre for Digestive Endoscopy, Sorbonne University, Saint-Antoine Hospital, APHP, Paris, France
  • Francesco Vito Mandarino

    10   Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy
  • Anahita Sadeghi

    11   Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Vicente Lorenzo-Zúñiga

    12   Endoscopy Unit, Hospital Universitari i Politècnic La Fe/IISLaFe, Valencia, Spain
  • Sandra Perez

    13   Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain
  • Konstantinos Triantafyllou

    14   Hepatogastroenterology Unit, Attikon University General Hospital, Athens, Greece
  • Maria Paula Curado

    15   Colorectal Cancer Department, AC Camargo Cancer Center, São Paulo, Brazil
  • Antonio Facciorusso

    16   Gastroenterology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Giulia Collatuzzo

    2   Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy
  • Cesare Hassan

    17   Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Ital
    18   IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
  • Franco Radaelli

    19   Gastroenterology Unit, Valduce Hospital, Como, Italy
  • Lorenzo Fuccio

    12   Endoscopy Unit, Hospital Universitari i Politècnic La Fe/IISLaFe, Valencia, Spain
  • on behalf of the ALIBI Study Group


Graphical Abstract

Preview

Abstract

Background Lower gastrointestinal bleeding (LGIB) is a common condition linked to increased morbidity, healthcare costs, and mortality. Currently, no prospectively validated prognostic model exists to predict mortality in patients with LGIB. Our aim was to develop and validate a risk score that could accurately predict in-hospital mortality of patients admitted for LGIB.

Methods Patient data from a nationwide cohort study in 15 centers in Italy (2019–2020) were used to derive the risk score, the Acute Lower gastrointestinal Bleeding and In-hospital mortality (ALIBI) score; the model was then externally validated in a cohort of consecutive patients hospitalized for LGIB in 12 centers from six countries (Italy, Spain, France, Greece, Iran, and Brazil) from 2022 to 2024. The main outcome was in-hospital mortality; we also reported rebleeding rates and the in-hospital mortality rate stratified by risk score and timing of colonoscopy.

Results Among 1198 patients in the derivation cohort, 105 (8.8%) re-bled and 41 (3.4%) died. Age, Charlson Co-morbidity Index, in-hospital onset, hemodynamic instability, and creatinine level were independent predictors of in-hospital mortality. The model demonstrated excellent discrimination (area under the receiver operating curve [AUROC] 0.81, 95%CI 0.75–0.87) and calibration. In the validation cohort (n = 752 patients), the model's good discrimination (AUROC 0.79, 95%CI 0.72–0.86) and calibration were confirmed. Patients were categorized as low (0–4 points; 1% mortality), intermediate (5–9 points; 4.6% mortality), or high risk (10–13 points; 19.1% mortality).

Conclusion A new validated score effectively predicts in-hospital mortality in patients with LGIB, aiding in their risk stratification and management.

Supplementary Material



Publikationsverlauf

Eingereicht: 23. Oktober 2024

Angenommen nach Revision: 17. Februar 2025

Accepted Manuscript online:
17. Februar 2025

Artikel online veröffentlicht:
04. April 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany